A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients

Clinical trial NCT03536143 · COMPLETED

Trial details

NCT number: NCT03536143
Sponsor: Krystal Biotech, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dystrophic Epidermolysis Bullosa

Start date: 2018-05-06
Primary completion: 2019-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.